The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease.
about
Behavioral and psychological symptoms of dementiaDonepezil for dementia due to Alzheimer's diseaseDepressive symptoms in neurodegenerative diseasesThe merits and problems of Neuropsychiatric Inventory as an assessment tool in people with dementia and other neurological disordersDrug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory TrialMaintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapyTreatment guidelines for Alzheimer's disease: redefining perceptions in primary care.Defining treatment response to donepezil in Alzheimer's disease: responder analysis of patient-level data from randomized, placebo-controlled studies.Effects of cholinesterase inhibitors on behavioural disturbances in Alzheimer's disease: a systematic review.Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials.Depressive Symptoms in Clinical and Incipient Alzheimer's Disease.Current and emerging drug treatment options for Alzheimer's disease: a systematic review.Efficacy and Tolerability of a Combination Treatment of Memantine and Donepezil for Alzheimer's Disease: A Literature Review Evidence.Managing medications in clinically complex elders: "There's got to be a happy medium".Cholinesterase inhibitor and N-methyl-D-aspartic acid receptor antagonist use in older adults with end-stage dementia: a survey of hospice medical directors.Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease.Pharmacological and Nonpharmacological Treatment for Apathy in Alzheimer Disease : A systematic review across modalitiesResults, rhetoric, and randomized trials: the case of donepezil.Translational research on the way to effective therapy for Alzheimer disease.Donepezil in Alzheimer's disease: From conventional trials to pharmacogeneticsAre cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine.Effectiveness of donepezil in reducing clinical worsening in patients with mild-to-moderate alzheimer's disease.Symptomatic and nonamyloid/tau based pharmacologic treatment for Alzheimer disease.Donepezil in Alzheimer's disease: an evidence-based review of its impact on clinical and economic outcomes.Psychiatric and behavioral symptoms in Alzheimer's disease and other dementias: etiology and management.Alzheimer's disease: the benefits of early treatment.NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer's Disease.A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease.Pharmacological management of behavioural and psychological disturbance in dementia.Treatments for behavioural disorders in neurodegenerative diseases: drug development strategies.Neuroleptic drugs in dementia: benefits and harm.Donepezil: a review.Trends in the prevalence of antipsychotic drug use among patients with Alzheimer's disease and other dementias including those treated with antidementia drugs in the community in the UK: a cohort study.Treatment of delusions in Alzheimer's disease--response to pharmacotherapy.Pharmacological treatment of the psychosis of Alzheimer's disease: what is the best approach?The threat of behavioral changes in dementiaACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia.Quality indicators for the care of dementia in vulnerable elders.Pharmacologic management of neuropsychiatric symptoms of Alzheimer disease.Treatment of Alzheimer's disease across the spectrum of severity.
P2860
Q21129432-8E3772F8-7691-4575-A445-294A18B14A39Q24244938-974CE62C-8F17-476A-8EEB-D4B2A0B34CFBQ26798063-6D236028-DD5C-43CC-A88E-4D11E22B2F70Q26823480-C87443DD-B678-4EB4-A63E-B9AF25D4EB9CQ28552171-50995AEB-C690-4629-AE6C-E44D1A2AD6B8Q30432684-619E510B-574C-4B64-8B61-B96B4CD7960AQ30443975-649D2A08-B5C9-4703-8376-4954A11ABDB2Q31166026-C7729BB4-4599-4CCD-8DDC-E96EB48B2522Q33265882-7E1CA2F4-CD71-42DA-BEEB-CA69694D22FDQ33912750-2ED35307-1B36-4538-B602-09E316387378Q34163446-28BFC134-51E6-450B-BDEF-C4A2C42C8DBEQ34222721-0A546C1C-74B7-465E-ABCD-AAE1CA53A01FQ34301111-61981F49-9D23-44C6-B5F6-5493789A7B63Q34311242-9B100249-DC12-4FFE-AACE-52420A522871Q34334170-D12CD8B5-D93A-481B-BDB4-44367E05D5ADQ34473820-07CADB0D-DB2F-46CE-B626-24BA9F07234CQ34552380-33B6763F-8474-4BE0-A43D-F5E59B10BFB9Q34594786-71174595-8996-4509-9D1B-97514C038BC6Q34684381-F37AFA16-015A-4CA2-BA38-E2DBB20FC0ABQ34965949-89102F81-71F6-4B37-9FC1-EEBA54494DBEQ34987695-0EB34462-4921-4638-A091-70771170EBA0Q35460043-7001117C-992C-43F7-973B-0F63DF1385B1Q35765716-30BE36D1-30DA-46EF-B0DF-513AE4F185DFQ35876403-B4F01DB4-4F96-4F5E-B310-6BC22A3129E4Q36244571-9BCD015B-436D-4DB6-854B-CB7BEF5A720FQ36249975-A2BC5856-6CC5-4730-8DC6-4DA30B24B7D3Q36310524-5B2D86DE-B526-487B-956F-69055337B872Q36329012-7D068802-75B7-4D4C-A6E1-97733B5BC92EQ36359134-4DDABA9D-0E3A-4FFA-972B-8D006C5BE181Q36399561-DA4E115D-1B3E-4196-92C3-837987516D34Q36484553-F28C4E24-40F8-4579-ADFA-F5D0812B9290Q36544994-56E21344-6D38-4F02-B753-0FA77B0F0AE2Q36545982-BDE343CB-E0BE-4652-9B32-719D9232EEB3Q36562571-C0603405-25D4-4EC5-B42F-9359B488720EQ36729609-F1F18E8B-08A0-438E-9E02-149F6B0B6673Q36866803-B7F99B15-92A6-429E-A138-201F1DBDE832Q36885358-534FB524-FE9A-4C71-8D3D-809EDDBA4AA2Q36957853-C7C62C92-A05B-4E0A-B547-61F048D17048Q37004363-F5D83D43-3E0F-4E43-89F9-D4D35FD59D89Q37017375-D64B575E-4CAB-473C-9312-85F4D2B8B78E
P2860
The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The efficacy of donepezil in t ...... symptoms in Alzheimer disease.
@ast
The efficacy of donepezil in t ...... symptoms in Alzheimer disease.
@en
The efficacy of donepezil in t ...... symptoms in Alzheimer disease.
@nl
type
label
The efficacy of donepezil in t ...... symptoms in Alzheimer disease.
@ast
The efficacy of donepezil in t ...... symptoms in Alzheimer disease.
@en
The efficacy of donepezil in t ...... symptoms in Alzheimer disease.
@nl
prefLabel
The efficacy of donepezil in t ...... symptoms in Alzheimer disease.
@ast
The efficacy of donepezil in t ...... symptoms in Alzheimer disease.
@en
The efficacy of donepezil in t ...... symptoms in Alzheimer disease.
@nl
P2093
P1433
P1476
The efficacy of donepezil in t ...... symptoms in Alzheimer disease.
@en
P2093
Olivieri S
Pandita-Gunawardena ND
Vethanayagam S
Wilkinson D
P304
P356
10.1212/01.WNL.0000129990.32253.7B
P407
P577
2004-07-01T00:00:00Z